Lamtor2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Molecular Function
LAMTOR2 is an essential component of the Ragulator complex, a key regulator of mTORC1 signaling:
Ragulator Complex
LAMTOR2 forms a heteropentameric complex with LAMTOR1 (p18), LAMTOR3 (p14), LAMTOR4 (HBXIP), and LAMTOR5. This complex localizes to the surface of late endosomes and lysosomes.
mTORC1 Activation
The Ragulator complex serves multiple critical functions:
Rag GTPase Localization: Recruits the Rag GTPases (RagA/B and RagC/D) to the lysosomal surface
GATOR Interaction: Interfaces with the GATOR1/GATOR2 complexes for amino acid sensing
mTORC1 Recruitment: Enables mTORC1 to be positioned near its activator (Rheb) on lysosomes
MAPK Signaling
Beyond mTORC1, LAMTOR2 also modulates MAPK/ERK signaling through its interactions with scaffold proteins.
Role in Neurodegeneration
Alzheimer's Disease
[mTOR](/mechanisms/mtor-signaling-pathway) Dysregulation: LAMTOR2/ragulator dysfunction contributes to mTORC1 hyperactivity observed in AD brains
Lysosomal Impairment: Defective ragulator affects lysosomal function and autophagy
Protein Clearance: Impaired mTORC1 regulation leads to defective clearance of [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau)
Parkinson's Disease
α-Synophagy: Ragulator dysfunction affects autophagy-lysosomal pathways critical for [α-synuclein](/proteins/alpha-synuclein) clearance
Lysosomal Storage: The lysosomal localization of ragulator links it to lysosomal dysfunction in PD (GBA mutations)
Metabolic Stress: mTORC1 dysregulation affects neuronal metabolism and survival
Lysosomal Storage Disorders
LAMTOR2 is crucial for proper lysosomal function. Mutations in LAMTOR genes cause primary lysosomal storage disorders characterized by accumulation of undegraded materials.
Signaling Pathway
Mermaid diagram (expand to render)
Gene Information
Clinical Significance
Mutations and Disease
Immunodeficiency: LAMTOR2 mutations cause combined immunodeficiency
Growth Retardation: Associated with growth impairment in patients
Neurodevelopmental Effects: Lysosomal dysfunction affects brain development
Therapeutic Implications
Key Publications
Sancak Y et al. "The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1." Science. 2008;320(5882):1496-1501. PMID: 18497260(https://pubmed.ncbi.nlm.nih.gov/18497260/)
Bar-Peled L et al. "Ragulator is a GEF for the Rag GTPases that activates mTOR by recruiting it to lysosomes." Cell. 2013;151(6):1256-1269. PMID: 24204285(https://pubmed.ncbi.nlm.nih.gov/24204285/)
Zoncu R et al. "mTOR: from growth signal integration to cancer, diabetes and ageing." Nat Rev Mol Cell Biol. 2011;12(1):21-35. PMID: 21157483(https://pubmed.ncbi.nlm.nih.gov/21157483/)
Kim J et al. "mTOR regulates cell growth and autophagy in neurodegeneration." Nat Rev Neurosci. 2021;22(5):281-297. PMID: 33772229(https://pubmed.ncbi.nlm.nih.gov/33772229/)
Settembre C et al. "A block in autophagy: a common pathogenic mechanism in neurodegenerative diseases." Autophagy. 2012;8(4):555-564. PMID: 22370611(https://pubmed.ncbi.nlm.nih.gov/22370611/)
Background
The study of Lamtor2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.